DaVita
DVA
#1719
Rank
C$16.78 B
Marketcap
C$261.53
Share price
-3.06%
Change (1 day)
48.22%
Change (1 year)
DaVita Inc. is an American company providing dialysis services for patients with chronic and acute kidney failure.

EPS for DaVita (DVA)

EPS in 2026 (TTM): C$17.41

According to DaVita's latest financial reports the company's current EPS (TTM) is C$17.42. In 2025 the company made an earnings per share (EPS) of C$14.12 a decrease over its 2024 EPS that were of C$15.39.

EPS history for DaVita from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C$17.4123.26%
2025C$14.12-8.25%
2024C$15.3944.94%
2023C$10.6227.26%
2022C$8.35-35.56%
2021C$12.9544.1%
2020C$8.9919.7%
2019C$7.51540.48%
2018C$1.17-76.07%
2017C$4.90-19.31%
2016C$6.07242.52%
2015C$1.77-62.87%
2014C$4.7713.43%
2013C$4.218.45%
2012C$3.88

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Universal Health Services
UHS
C$34.65 98.96%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
C$16.98-2.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Tenet Healthcare
THC
C$36.45 109.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Pediatrix Medical Group
MD
C$2.95-83.04%๐Ÿ‡บ๐Ÿ‡ธ USA